Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer

• Daniel Holzinger,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Ivan Danilovic,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Rudolf Seemann,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Gabriela Kornek,

  Affiliation Department of Medicine I, Medical University of Vienna, Austria

  ⨯
• Johannes Engelmann,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Robert Pillerstorff,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Simone Holawe,

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯
• Amanda Psyrri,

  Affiliation Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece

  ⨯
• Boban M. Erovic,

  Affiliation Department of Otolaryngology—Head and Neck Surgery, Medical University of Vienna, Austria

  ⨯
• Gregory Farwell,

  Affiliation Department of Otolaryngology-Head and Neck Surgery, University of California, Davis, Sacramento, United States of America

  ⨯
• Christos Perisanidis

  * E-mail: christos.perisanidis@meduniwien.ac.at

  Affiliation Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria

  ⨯